The new obesity pill arrives in Israel: once a day, no injection - and will cost about a thousand shekels | Who is it suitable for?

The new obesity drug, orforglipron by Eli Lilly, will arrive in Israel on September 15. Israel will be the fourth country in the world to receive it. The drug is taken as a daily pill, does not require fasting or refrigeration, and its price ranges from 691 to 1,146 shekels.

The new obesity drug, orforglipron by Eli Lilly, will arrive at pharmacies in Israel on September 15, 2026. Israel will be the fourth country in the world where the drug is commercially available, after the United States, the United Kingdom, and the United Arab Emirates. The drug is taken as one pill a day, unlike existing injectable medications. It does not require fasting, a fixed time of intake, restriction on drinking water, or refrigeration – a significant logistical advantage. The drug is intended for adults with obesity or overweight with a related disease, in combination with diet and exercise. It is available in six dosages, from 0.8 mg to 17.2 mg. Its price ranges from 691.59 shekels to 1,146.46 shekels. The drug has been submitted for approval to the Ministry of Health and for the current health basket.

The new obesity pill arrives in Israel: once a day, no injection - and will cost about a thousand shekels | Who is it suitable for?